NCT05403723 2026-02-19Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLCUniversity of Maryland, BaltimorePhase 1 Suspended50 enrolled
NCT05337735 2025-10-09A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare CancersM.D. Anderson Cancer CenterPhase 2 Suspended140 enrolled